Cell Death — Necrosis and Apoptosis

NECROSIS: MECHANISMS OF PATHOLOGICAL CELL DEATH

Loss of Membrane Integrity and Energy Failure

• Necrosis results from severe, acute cellular injury exceeding the cell's capacity for adaptation, typically initiated by ischemia, toxins, trauma, or infection
• Mechanisms center on ATP depletion and failure of ATP-dependent pumps (Na⁺/K⁺-ATPase), leading to loss of ionic homeostasis
• Intracellular Na⁺ accumulation drives osmotic water influx, causing cellular swelling (oncosis) and organelle enlargement
• Calcium influx through damaged membrane and release from depleted ER stores activates proteases (calpains), phospholipases, and endonucleases
• Cell membrane rupture occurs as a consequence of severe swelling and enzymatic degradation, causing release of intracellular contents (danger-associated molecular patterns or DAMPs)

Morphological Progression

• Early changes include cell swelling (acute cellular edema), loss of cell-cell contacts, and mitochondrial swelling with cristae dissolution
• Nuclear changes occur late and include pyknosis (nuclear shrinkage with heterochromatin clumping), followed by karyorrhexis (random fragmentation)
• Organelle preservation is characteristic (mitochondria remain visible) contrasting with apoptosis
• Lack of apoptotic bodies and intact membrane initially (until rupture occurs)

APOPTOSIS: MECHANISMS OF PROGRAMMED CELL DEATH

Intrinsic (Mitochondrial) Pathway

• Initiated by internal stress signals (hypoxia, DNA damage, growth factor withdrawal, ROS) sensed by BH3-only proteins (BAX, BAK, BID, BIM)
• BH3 proteins activate pro-apoptotic BCL-2 proteins (BAX, BAK), which oligomerize in outer mitochondrial membrane
• Oligomerized BAX/BAK form membrane permeability transition pores, releasing cytochrome c and other pro-apoptotic factors (Smac/DIABLO, AIF, EndoG)
• Released cytochrome c binds APAF1 (apoptotic protease-activating factor 1) in cytoplasm, forming the apoptosome
• Apoptosome recruits and activates procaspase-9 through proximity, generating active caspase-9 (initiator caspase)
• Anti-apoptotic proteins (BCL-2, BCL-xL, MCL-1) sequester BH3-only proteins and prevent BAX/BAK activation
• This pathway is triggered by p53-dependent transcription following DNA damage, hypoxia sensors, and stress kinases (JNK, p38)

Extrinsic (Death Receptor) Pathway

• Initiated by binding of death ligands (FasL, TNFα, TRAIL) to death receptors (Fas/FasR, TNF-R1, TRAIL-R)
• Death receptors contain death domains in cytoplasmic tails that recruit adaptor proteins (FADD, TRADD)
• FADD recruits procaspase-8, forming the death-inducing signaling complex (DISC)
• Activated caspase-8 cleaves and activates executioner caspases (caspase-3, caspase-7) directly
• Caspase-8 also cleaves BID (BH3-only protein), which translocates to mitochondria to amplify intrinsic pathway (cross-talk between pathways)

Endoplasmic Reticulum (ER) Stress Pathway

• Unfolded protein accumulation in ER activates IRE1α, ATF6, and PERK stress sensors
• These sensors activate transcription of CHOP and pro-apoptotic genes, upregulate calcium release from ER, and activate caspase-12
• Sustained ER stress promotes BAX activation and mitochondrial-dependent apoptosis

Executioner Phase (Common to All Pathways)

• Caspase-3 and caspase-7 activation represents the point of no return, cleaving critical substrates
• Substrates include PARP (poly-ADP-ribose polymerase; produces characteristic 89 kDa fragment on Western blot), lamins (nuclear scaffold degradation), and α-fodrin
• ICAD (inhibitor of caspase-activated DNase) is cleaved, releasing CAD (caspase-activated DNase) into nucleus
• CAD causes internucleosomal DNA fragmentation at 180-200 bp intervals ("DNA ladder" on gel electrophoresis), characteristic of apoptosis
• Phosphatidylserine externalization occurs due to caspase-3 cleavage of scramblase inhibitors, marking apoptotic cells for recognition and phagocytosis by macrophages via PS receptors
• Mitochondrial cytochrome c release is the critical decision point for irreversibility

Morphological Features of Apoptosis

• Cell shrinkage (pyknosis at cellular level) while maintaining membrane integrity
• Nuclear condensation (pyknosis) with dense, crescent-shaped heterochromatin at nuclear periphery
• Fragmented nuclei (karyorrhexis) producing apoptotic bodies containing intact organelles and condensed chromatin
• Apoptotic bodies are membrane-enclosed fragments containing nucleus or nuclear fragments, engulfed by neighboring cells and phagocytes via efferocytosis
• No inflammatory response because membrane remains intact and cell contents are not released
• Process occurs in 30 minutes to several hours

COMPARISON OF NECROSIS VS. APOPTOSIS

NECROSIS ETIOLOGIES

Ischemic Injury (Most Common)

• Myocardial infarction due to coronary artery occlusion; infarct core shows coagulative necrosis
• Cerebral infarction (stroke); brain shows liquefactive necrosis due to lack of structural proteins
• Acute mesenteric ischemia; intestinal necrosis follows superior mesenteric artery thrombosis
• Limb ischemia from arterial occlusion or severe hypotension

Direct Toxic/Chemical Injury

• Heavy metals (mercury, arsenic, lead) causing hepatotoxicity and nephrotoxicity
• Acetaminophen overdose causing massive hepatic necrosis
• Corrosive substances (strong acids/bases) causing mucosal and tissue necrosis
• Drug reactions (chemotherapy agents, NSAIDs, antibiotics)

Microbial Infection

• Bacterial toxins (e.g., alpha toxin from Clostridium perfringens causing gas gangrene)
• Severe infections with overwhelming bacterial/fungal load causing tissue destruction
• Viral hepatitis causing hepatocyte necrosis
• Tuberculosis with caseous necrosis (granulomatous necrosis with unique morphology)

Traumatic Injury

• Crush injuries, burn injuries causing direct cellular disruption
• Severe mechanical trauma exceeding cellular repair capacity
• Thermal injury with protein denaturation

Immunologic Injury

• Antibody-mediated complement activation causing cell lysis
• Cytotoxic T-cell granule-mediated killing (though apoptosis is primary mechanism)
• Cytokine-induced injury (TNFα toxicity in sepsis)

Radiation Injury

• High-dose ionizing radiation causing DNA double-strand breaks and cell death
• Acute radiation syndrome with GI tract and bone marrow necrosis
• Thermal burns from radiation

Metabolic Derangements

• Severe hypoglycemia causing neuronal necrosis
• Acute hyperammonemia in liver failure causing astrocyte necrosis (cerebral edema)

APOPTOSIS ETIOLOGIES

Physiologic/Developmental Apoptosis

• Digit/web formation during embryogenesis requires massive apoptosis of interdigital mesenchyme
• Thymic selection eliminating 95% of developing thymocytes that don't recognize self-MHC or recognize self-antigen
• Ovarian follicle atresia and prostate involution after hormone withdrawal
• Hair follicle cycling; intestinal epithelial turnover every 3-5 days

DNA Damage-Induced Apoptosis

• p53 activation by DNA damage triggers transcription of pro-apoptotic genes (BAX, PUMA, NOXA)
• Cancer chemotherapy (alkylating agents, topoisomerase inhibitors) causing DNA damage
• Radiation therapy inducing double-strand breaks
• Carcinogenic agents causing DNA adducts

Growth Factor Withdrawal

• IL-2 withdrawal causing lymphocyte death after immune response resolution
• Loss of survival signals from ECM or growth factors in inappropriate context
• Trophic factor deprivation in neurodegeneration

Oxidative Stress

• Excessive ROS from ischemia-reperfusion injury, mitochondrial dysfunction, or inflammatory activation
• ROS-induced damage to lipids, proteins, and DNA
• Ferroptosis as iron-dependent cell death variant involving lipid peroxidation

Endoplasmic Reticulum Stress

• Misfolded protein accumulation (e.g., in neurodegenerative diseases)
• Viral infection with excessive protein synthesis demands
• Pharmacologic ER stress induction

Immune Activation

• Activation-induced cell death (AICD) in lymphocytes via Fas-FasL interaction
• Chronic antigen stimulation triggering apoptosis of activated T cells
• Cytotoxic lymphocyte killing via Fas/FasL or perforin/granzyme

Viral Infection

• Some viruses (e.g., certain herpesviruses) induce apoptosis; others (poxviruses, hepatitis C) evade it
• Immune response to infection triggering bystander apoptosis

Metabolic Stress

• Hypoxia-induced apoptosis in ischemic tissue (delayed, occurring after initial necrosis)
• Nutrient deprivation triggering AMPK-mediated apoptosis
• Calcium overload causing mitochondrial dysfunction

NECROSIS: CLINICAL AND PATHOLOGICAL MANIFESTATIONS

Acute Ischemic Injury (Myocardial Infarction)

• Chest pain (described as crushing, substernal, radiating) resulting from myocardial injury and inflammatory mediator release
• Dyspnea from acute heart failure due to loss of contractility and accumulation of necrotic, non-functional myocardium
• Arrhythmias from electrical instability in zone of injury and peri-infarct region
• Cardiogenic shock if extensive necrosis (>40% LV) occurs
• Gross pathology: Initially pale, then hemorrhagic (4-12 hours); tan/brown discoloration by 24-48 hours with granulation tissue by 1-2 weeks
• Histology: Coagulative necrosis with preserved architecture initially (cells look "ghost-like" with loss of nuclei and cytoplasmic detail); extensive neutrophilic infiltration by 24-48 hours

Acute Hepatic Necrosis (Acetaminophen Toxicity, Viral Hepatitis)

• Jaundice (yellow discoloration of sclera, skin) from bilirubin accumulation due to hepatocyte loss
• Hepatic encephalopathy (asterixis, confusion, coma) from ammonia and other neurotoxic metabolites accumulating when liver cannot detoxify
• Coagulopathy with prolonged PT/INR from loss of synthesis of clotting factors
• Hepatomegaly initially, then hepatic shrinkage (acute yellow atrophy) in fulminant hepatic failure
• Gross: Liver appears pale yellow-tan (fatty infiltration), soft and friable with necrotic tissue
• Histology: Hepatocyte necrosis with loss of nuclei and pale cytoplasm, extensive inflammatory infiltrate, architectural collapse

Acute Kidney Injury (Acute Tubular Necrosis)

• Oliguria/anuria (reduced urine output <400-500 mL/day) from loss of tubular epithelial function and glomerular filtration
• Hyperkalemia with ECG changes (peaked T waves, prolonged PR interval) from K⁺ release by damaged cells and reduced excretion
• Uremia with nausea, vomiting, confusion from accumulation of nitrogenous wastes
• Muddy brown casts on urinalysis from necrotic cell debris and pigment
• Histology: Tubular epithelial necrosis with loss of brush border, detachment of cells into lumen, intact basement membrane

Cerebral Infarction (Ischemic Stroke)

• Sudden neurologic deficit (contralateral weakness, speech difficulties, visual loss) corresponding to vascular territory
• Increased intracranial pressure from cerebral edema (vasogenic edema from blood-brain barrier disruption) beginning at 24-48 hours
• Gross: Initially brain appears swollen and soft; later pale or discolored tissue (liquefactive necrosis)
• Histology: Liquefactive necrosis with loss of structure, neuron and glial cell death, cavitation and cystic change (unique to brain due to lack of supporting connective tissue)
• MRI/CT: Initial hypodensity on CT; FLAIR hyperintensity on MRI; diffusion restriction on DWI

Skin and Soft Tissue Necrosis (Burns, Gangrene)

• Tissue blackening/charring (full-thickness burns) with loss of viability
• Gas gangrene from Clostridium perfringens with crepitus (air in tissues), myonecrosis, and systemic toxicity
• Liquefactive necrosis of skin and subcutaneous tissues
• Gross: Black, hard, demarcated tissue (coagulative) or soft, purulent debris (liquefactive)
• Systemic signs: Fever, tachycardia, hypotension, shock from inflammatory mediator release and infection

APOPTOSIS: CLINICAL PRESENTATIONS

Physiologic Apoptosis (Usually Asymptomatic)

• Normal tissue turnover in intestinal mucosa (100+

Initial (biochemical) evidence — leakage means necrosis

• Serum enzyme/protein release: troponin I/T, CK-MB, AST/ALT, LDH, myoglobin, lipase enter blood only when the plasma membrane ruptures. A rising-and-falling troponin with at least one value above the 99th percentile upper reference limit, plus ischemic symptoms/ECG/imaging, defines myocardial infarction under the Fourth Universal Definition of Myocardial Infarction (ESC/ACC/AHA/WHF). Apoptosis, which preserves membrane integrity until phagocytosis, produces no enzyme leak — a key exam discriminator.
• Inflammatory/DAMP markers: leukocytosis, fever, and elevated CRP accompany necrosis; apoptosis is biochemically silent.

Confirmatory/gold standard — tissue

• H&E histopathology remains definitive. Necrosis: increased cytoplasmic eosinophilia (loss of basophilic RNA, denatured protein), pyknosis → karyorrhexis → karyolysis, and a pattern that names the etiology — coagulative (ischemia in all solid organs, "ghost cells" with preserved architecture), liquefactive (brain infarct, abscess), caseous (TB, fungal granuloma), fat (pancreatitis, chalky saponification), fibrinoid (vasculitis, malignant hypertension), gangrenous (dry = coagulative, wet = superimposed liquefactive).
• Apoptosis assays: annexin V flow cytometry detects externalized phosphatidylserine — annexin V⁺/propidium iodide⁻ marks early apoptosis, annexin V⁺/PI⁺ late apoptosis or necrosis; TUNEL labels 3′-OH DNA nicks; agarose gel shows a 180–200 bp DNA ladder versus a random smear in necrosis; immunohistochemistry for cleaved caspase-3 and the 89 kDa PARP fragment confirms caspase activation.
• Electron microscopy distinguishes irreversible injury (membrane defects, mitochondrial amorphous densities) from reversible swelling.

Named criteria in clinical use

• Revised Atlanta Classification defines necrotizing pancreatitis; contrast-enhanced CT showing non-enhancing parenchyma is the confirmatory study endorsed by the American College of Gastroenterology.
• Sgarbossa criteria are applied when LBBB or paced rhythm obscures the ECG — a new LBBB alone is not a stand-alone STEMI criterion.

Immediate stabilization

• Airway, oxygenation, perfusion: necrosis is fundamentally ATP failure, so restoring substrate delivery is first. Isotonic crystalloid for shock; treat hyperkalemia from lysed cells emergently (calcium gluconate to stabilize membranes, then insulin with dextrose, then removal).

Cause-directed first-line therapy

• Reperfusion for ischemic necrosis: per ACC/AHA, primary PCI is preferred for STEMI with fibrinolysis when timely PCI is unavailable; per AHA/ASA, IV thrombolysis (alteplase or tenecteplase) within the approved window plus mechanical thrombectomy for large-vessel occlusion.
• Antidote/toxin removal: N-acetylcysteine replenishes glutathione and detoxifies NAPQI in acetaminophen hepatotoxicity, dosed by the Rumack–Matthew nomogram; AASLD guidance supports NAC in acute liver failure.
• Antimicrobials plus source control: for necrotizing soft-tissue infection, IDSA recommends emergent surgical debridement with broad-spectrum coverage — an anti-MRSA agent (vancomycin, dosed to a 24-hour AUC/MIC of 400–600 per the 2020 IDSA/ASHP consensus) plus a beta-lactam/beta-lactamase inhibitor (piperacillin-tazobactam) and clindamycin for ribosomal toxin suppression.
• Supportive care for ATN: KDIGO recommends volume optimization, withdrawal of nephrotoxins, and renal replacement therapy for refractory hyperkalemia, acidosis, volume overload, or uremia.

Escalation and definitive management

• Surgical/interventional: debridement, amputation for gangrene, fasciotomy for compartment syndrome, and step-up minimally invasive necrosectomy (drainage first) for infected pancreatic necrosis per ACG.
• Pharmacologic apoptosis induction in oncology: the BCL-2 inhibitor venetoclax restores intrinsic-pathway apoptosis in CLL/AML (NCCN); ATRA plus arsenic trioxide in APL.

Contraindicated/avoid

• Prophylactic antibiotics for sterile pancreatic necrosis (ACG).
• Delaying operative exploration for imaging in suspected necrotizing fasciitis.
• Loop diuretics or "renal-dose" dopamine to treat established AKI, and hydroxyethyl starch (KDIGO).

Systemic consequences of necrosis

• SIRS, ARDS, and multiorgan failure: DAMPs (HMGB1, mitochondrial DNA, ATP) released through ruptured membranes ligate pattern-recognition receptors, producing sterile inflammation indistinguishable clinically from sepsis. Signal: fever and leukocytosis with negative cultures.
• Hyperkalemia and rhabdomyolysis — emergency: myocyte lysis releases K⁺, phosphate, and myoglobin; peaked T waves progressing to a sine wave demand immediate treatment. Myoglobin casts cause pigment nephropathy (dark urine, heme-positive dipstick without RBCs).
• Compartment syndrome — emergency: swelling in a fixed fascial space raises pressure above capillary perfusion, propagating necrosis. Signal is pain out of proportion and pain on passive stretch; pulselessness is late.
• Dystrophic calcification: calcium deposits in necrotic tissue with normal serum calcium (contrast metastatic calcification in hypercalcemia).

Organ-specific

• Post-MI: ventricular fibrillation/pulseless VT — the shockable pair — is the leading early cause of death (emergency, immediate defibrillation); days 3–14, macrophage-derived collagenase weakens the infarct, causing free-wall rupture with tamponade, papillary muscle rupture with acute mitral regurgitation, or VSD (new harsh murmur plus shock).
• Cerebral infarct: cytotoxic then vasogenic edema peaks days 2–5 causing herniation (emergency); liquefaction leaves a gliotic cyst; hemorrhagic transformation is the feared thrombolysis complication.
• Pancreatic necrosis: infected necrosis and walled-off necrosis; saponification consumes calcium → hypocalcemia with Chvostek/Trousseau signs.
• Reperfusion injury: reoxygenation generates ROS and calcium overload; contraction band necrosis is the histologic marker.

Treatment- and apoptosis-related

• Tumor lysis syndrome — emergency: massive chemotherapy- or venetoclax-induced apoptosis releases K⁺, phosphate, and nucleic acids → hyperuricemia, hypocalcemia, AKI (Cairo–Bishop criteria); prevent with hydration and rasburicase/allopurinol.
• Failed apoptosis: BCL-2 overexpression from t(14;18) causes follicular lymphoma; Fas/FasL defects cause autoimmune lymphoproliferative syndrome.

• Coagulative necrosis occurs in every organ except the brain: acidosis from ischemia denatures lysosomal enzymes, so architecture is preserved as ghost cells. The CNS lacks a collagenous stroma and is enzyme-rich, so infarcts undergo liquefactive necrosis and cavitate. Do not swap these.
• Apoptosis is ATP-dependent and non-inflammatory; necrosis is ATP-depleted and intensely inflammatory. A shrunken, deeply eosinophilic cell with a condensed crescentic nucleus and no surrounding neutrophils is apoptosis (Councilman body in viral hepatitis/yellow fever).
• Caspase map: caspase-8 = extrinsic (Fas/FADD/DISC), caspase-9 = intrinsic (cytochrome c + APAF1 = apoptosome), caspase-3/7 = executioner. Cytochrome c release is the point of no return.
• The association examiners test: t(14;18) places BCL-2 under the IgH promoter in follicular lymphoma — the tumor grows because cells fail to die, not because they divide faster. Fas/FasL mutations cause autoimmune lymphoproliferative syndrome; defective apoptosis of autoreactive thymocytes underlies loss of central tolerance.
• Best next step: pain out of proportion, crepitus, or bullae over an erythematous limb → emergent surgical exploration, not CT and not antibiotics alone (IDSA).
• Common distractor 1: TUNEL is not specific for apoptosis — necrotic DNA fragmentation also labels. Annexin V⁺/PI⁻ is the cleaner early-apoptosis marker, and the 180–200 bp ladder (versus a random smear) is the classic gel finding.
• Common distractor 2: dystrophic calcification of necrotic tissue happens with normal serum calcium; metastatic calcification requires hypercalcemia.
• Reperfusion pearl: contraction band necrosis and wavy fibers indicate reperfused infarct; on ECG, a new LBBB is not by itself a STEMI equivalent — apply Sgarbossa criteria.